Innovative Drug Concept Sees Partial Recovery as Beijing Hotgen Biotech and Inner Mongolia Furui Medical Science Both Surge Over 10%

Deep News09-11

On September 11th, the innovative drug concept showed partial recovery in the afternoon session, with Beijing Hotgen Biotech Co.,Ltd. and Inner Mongolia Furui Medical Science Co.,Ltd. both rising over 10%. Previously, Jimin Health posted 6 limit-up days within a 12-day period. Shutaishan, RongChang Bio, Changshan Pharma, and Medicilon were also among the top gainers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment